This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is an immunosuppressive drug that is becoming the drug of choice for transplantation. It may be of use in the management of severe autoimmune diseases.

Cyclosporin blocks cytotoxic T cell activation by:

  • inhibits the formation of a calcineurin-dependent factor essential for the transcription of the interleukin-2 gene, thereby reducing production of interleukin (IL2) by activated T cells and inhibits expression of IL-2 receptors by cytotoxic T cells
  • reduces the response of T helper cells to IL-1
  • does not affect proliferation of suppressor T cells
  • inhibits interferon production by lymphocytes

The bioavailability of cyclosporin A is dependent on the presence of bile salts which may be reduced in patients with liver transplantation. This problem however has been significantly reduced since the advent of a micro-emulsion formulation of cyclosporin whose absorption is independent of bile in the small intestine.

Patients treated with cyclosporin A should have their blood pressure and renal function monitored regularly.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page